Literature DB >> 20004134

Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience.

Doenja Hertog1, Isaäc van der Waal.   

Abstract

The 40-years of experience in a single institution with the treatment of previously untreated ameloblastoma have been reported, followed by a management protocol. Retrospectively, 25 consecutive patients treated between 1969 and 2009 have been analyzed. In 11 patients, a preoperative diagnosis of ameloblastoma was available. In the remaining 14 patients the diagnosis of ameloblastoma was a postoperative one. For the recurrence rate a minimum follow-up period of 5 years was observed; 20 patients met these criteria. After primary radical surgery in five patients, no recurrences were observed. In case of conservative surgical treatment, performed in 15 patients, a recurrence was observed in eight (53%) of them. Six of these patients were then treated successfully by radical surgery, while two patients refused such surgical approach. In one of the patients with a recurrence a cervical lymph node metastasis was detected at the same time, resulting in a diagnosis of metastasizing ameloblastoma.

Entities:  

Mesh:

Year:  2009        PMID: 20004134     DOI: 10.1016/j.oraloncology.2009.11.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

1.  Is conservative surgery a better choice for the solid/multicystic ameloblastoma than radical surgery regarding recurrence? A systematic review.

Authors:  Yuri Slusarenko da Silva; Natalia Aguiar Tartaroti; Daniel Isaac Sendyk; Maria Cristina Zindel Deboni; Maria da Graça Naclério-Homem
Journal:  Oral Maxillofac Surg       Date:  2018-09-06

2.  Ameloblastoma: an aggressive lesion of the mandible.

Authors:  M S Suma; K J Sundaresh; R Shruthy; Rachappa Mallikarjuna
Journal:  BMJ Case Rep       Date:  2013-10-09

Review 3.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

4.  Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience.

Authors:  Ramakant Dandriyal; Vishakha Lal; Kolli Yada Giri; Niranjanaprasad Indra Bavanthabettu; Archana Chaurasia; Swati Pant
Journal:  J Maxillofac Oral Surg       Date:  2022-03-17

Review 5.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

6.  Follicular ameloblastoma presenting as a sinonasal tumor.

Authors:  Sh Shahidi; P Bronoosh; Y Daneshbod
Journal:  Iran Red Crescent Med J       Date:  2012-02-01       Impact factor: 0.611

7.  Ameloblastomas: clinicopathological features from 70 cases diagnosed in a single oral pathology service in an 8-year period.

Authors:  Andressa-Incerte Filizzola; Teresa-Cristina-Ribeiro Bartholomeu-dos-Santos; Fábio-Ramôa Pires
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-11-01

Review 8.  Odontogenic tumors: where are we in 2017 ?

Authors:  John M Wright; Merva Soluk Tekkesin
Journal:  J Istanb Univ Fac Dent       Date:  2017-12-02

9.  Ameloblastoma: Management and Outcome.

Authors:  Mohammad Adeel; Muhammad Shaheryar Ahmed Rajput; Asif Ali Arain; Maqbool Baloch; Mumtaz Khan
Journal:  Cureus       Date:  2018-10-10

10.  Regeneration of mandibular ameloblastoma defect with the help of autologous dental pulp stem cells and buccal pad of fat stromal vascular fraction.

Authors:  K Manimaran; Rohini Sharma; S Sankaranarayanan; S Mahendra Perumal
Journal:  Ann Maxillofac Surg       Date:  2016 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.